[Latest News][6]

Best Stock Advisory Company in Indore
Best Stock Option Tips Provider
Budget 2018
Call Put Option Tips
Commodity Market Tips
Commodity Tips
F&O Tips
Gold
Indian Stock Market Tips
Market
MCX Tips
Mcx Trading Tips
NCDEX tips
Nifty Future Tips
Nifty Option Tips
NSE BSE
NSE BSE stock
NSE BSE stock Market
Option Tips
Option Trading Tips
Share Market Tips
Silver
Stock Market Tips
Stock Option Market Tips
Stock Option Tips

India's antitrust watchdog orders probe into Roche cancer drug

MUMBAI - India's antitrust regulator has ordered a probe into Swiss drugmaker Roche for allegedly using anti-competitive practices to restrict cheaper copies of a blockbuster cancer drug from reaching patients. Trastuzumab has been a mainstay of Roche's profit for years and brought in global sales of about $6.7 billion in 2016, but it has been challenged in the last three years by biosimilars which are sold at about a 25 percent discount to the original.


India's Biocon and U.S. firm Mylan, which together sell biosimilars of the drug in over a dozen countries including India, filed a complaint with the Competition Commission of India (CCI) last year alleging Roche misled doctors and regulators to thwart competition to trastuzumab. India, with among the highest number of cancer patients in the world, is a big market for trastuzumab, which is indicated to treat certain forms of breast and gastric cancer.

Now watch every updates regarding Share and Stock market just with a simple click here: - http://www.ripplesadvisory.com/nifty-future-.php

No comments:

Post a Comment

Note: only a member of this blog may post a comment.

Start typing and press Enter to search